The effect of vitamin C on nitroglycerin‐mediated vasodilation in individuals with and without the aldehyde dehydrogenase 2 polymorphism
Aims To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact mechanism of GTN bioactivation remains uncertain. Mitochondrial aldehyde dehydrogenase (ALDH‐2) has been proposed as the primary enzyme...
Saved in:
Published in | British journal of clinical pharmacology Vol. 89; no. 9; pp. 2767 - 2774 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
01.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aims
To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact mechanism of GTN bioactivation remains uncertain. Mitochondrial aldehyde dehydrogenase (ALDH‐2) has been proposed as the primary enzyme responsible for this bioactivation process. Evidence for the importance of ALDH‐2 in GTN bioactivation has been inconsistent, particularly in human models. An alternative hypothesis suggests that decreased ALDH‐2 activity leads to accumulation of reactive cytotoxic aldehydes, which either inhibit the vasoactive product(s) of GTN or impair other enzymatic pathways involved in the bioactivation of GTN. We investigated the effect of supplemental vitamin C on vascular responses to GTN in healthy volunteers of East Asian descent, of whom 12 with and 12 without the ALDH‐2 polymorphism participated.
Methods
Subjects underwent 2 sequential brachial artery infusions of GTN at rates of 5, 11 and 22 nmol/min, separated by a 30‐min washout period. The GTN infusions were carried out in the presence and absence of vitamin C using a randomized, crossover design. Venous occlusion plethysmography was used to measure forearm blood flow responses to GTN.
Results
Compared to subjects with functional ALDH‐2, the variant group exhibited blunted hemodynamic responses to intra‐arterial GTN infusions, although this reduction in response was not statically significant. Contrary to our hypothesis, vitamin C had an inhibitory effect on GTN mediated vasodilation as compared to GTN during saline in both groups.
Conclusion
We conclude that vitamin C did not augment the acute vascular response to GTN in those with the ALDH‐2 polymorphism. |
---|---|
AbstractList | To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact mechanism of GTN bioactivation remains uncertain. Mitochondrial aldehyde dehydrogenase (ALDH-2) has been proposed as the primary enzyme responsible for this bioactivation process. Evidence for the importance of ALDH-2 in GTN bioactivation has been inconsistent, particularly in human models. An alternative hypothesis suggests that decreased ALDH-2 activity leads to accumulation of reactive cytotoxic aldehydes, which either inhibit the vasoactive product(s) of GTN or impair other enzymatic pathways involved in the bioactivation of GTN. We investigated the effect of supplemental vitamin C on vascular responses to GTN in healthy volunteers of East Asian descent, of whom 12 with and 12 without the ALDH-2 polymorphism participated.AIMSTo mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact mechanism of GTN bioactivation remains uncertain. Mitochondrial aldehyde dehydrogenase (ALDH-2) has been proposed as the primary enzyme responsible for this bioactivation process. Evidence for the importance of ALDH-2 in GTN bioactivation has been inconsistent, particularly in human models. An alternative hypothesis suggests that decreased ALDH-2 activity leads to accumulation of reactive cytotoxic aldehydes, which either inhibit the vasoactive product(s) of GTN or impair other enzymatic pathways involved in the bioactivation of GTN. We investigated the effect of supplemental vitamin C on vascular responses to GTN in healthy volunteers of East Asian descent, of whom 12 with and 12 without the ALDH-2 polymorphism participated.Subjects underwent 2 sequential brachial artery infusions of GTN at rates of 5, 11 and 22 nmol/min, separated by a 30-min washout period. The GTN infusions were carried out in the presence and absence of vitamin C using a randomized, crossover design. Venous occlusion plethysmography was used to measure forearm blood flow responses to GTN.METHODSSubjects underwent 2 sequential brachial artery infusions of GTN at rates of 5, 11 and 22 nmol/min, separated by a 30-min washout period. The GTN infusions were carried out in the presence and absence of vitamin C using a randomized, crossover design. Venous occlusion plethysmography was used to measure forearm blood flow responses to GTN.Compared to subjects with functional ALDH-2, the variant group exhibited blunted hemodynamic responses to intra-arterial GTN infusions, although this reduction in response was not statically significant. Contrary to our hypothesis, vitamin C had an inhibitory effect on GTN mediated vasodilation as compared to GTN during saline in both groups.RESULTSCompared to subjects with functional ALDH-2, the variant group exhibited blunted hemodynamic responses to intra-arterial GTN infusions, although this reduction in response was not statically significant. Contrary to our hypothesis, vitamin C had an inhibitory effect on GTN mediated vasodilation as compared to GTN during saline in both groups.We conclude that vitamin C did not augment the acute vascular response to GTN in those with the ALDH-2 polymorphism.CONCLUSIONWe conclude that vitamin C did not augment the acute vascular response to GTN in those with the ALDH-2 polymorphism. Aims To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact mechanism of GTN bioactivation remains uncertain. Mitochondrial aldehyde dehydrogenase (ALDH‐2) has been proposed as the primary enzyme responsible for this bioactivation process. Evidence for the importance of ALDH‐2 in GTN bioactivation has been inconsistent, particularly in human models. An alternative hypothesis suggests that decreased ALDH‐2 activity leads to accumulation of reactive cytotoxic aldehydes, which either inhibit the vasoactive product(s) of GTN or impair other enzymatic pathways involved in the bioactivation of GTN. We investigated the effect of supplemental vitamin C on vascular responses to GTN in healthy volunteers of East Asian descent, of whom 12 with and 12 without the ALDH‐2 polymorphism participated. Methods Subjects underwent 2 sequential brachial artery infusions of GTN at rates of 5, 11 and 22 nmol/min, separated by a 30‐min washout period. The GTN infusions were carried out in the presence and absence of vitamin C using a randomized, crossover design. Venous occlusion plethysmography was used to measure forearm blood flow responses to GTN. Results Compared to subjects with functional ALDH‐2, the variant group exhibited blunted hemodynamic responses to intra‐arterial GTN infusions, although this reduction in response was not statically significant. Contrary to our hypothesis, vitamin C had an inhibitory effect on GTN mediated vasodilation as compared to GTN during saline in both groups. Conclusion We conclude that vitamin C did not augment the acute vascular response to GTN in those with the ALDH‐2 polymorphism. To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact mechanism of GTN bioactivation remains uncertain. Mitochondrial aldehyde dehydrogenase (ALDH-2) has been proposed as the primary enzyme responsible for this bioactivation process. Evidence for the importance of ALDH-2 in GTN bioactivation has been inconsistent, particularly in human models. An alternative hypothesis suggests that decreased ALDH-2 activity leads to accumulation of reactive cytotoxic aldehydes, which either inhibit the vasoactive product(s) of GTN or impair other enzymatic pathways involved in the bioactivation of GTN. We investigated the effect of supplemental vitamin C on vascular responses to GTN in healthy volunteers of East Asian descent, of whom 12 with and 12 without the ALDH-2 polymorphism participated. Subjects underwent 2 sequential brachial artery infusions of GTN at rates of 5, 11 and 22 nmol/min, separated by a 30-min washout period. The GTN infusions were carried out in the presence and absence of vitamin C using a randomized, crossover design. Venous occlusion plethysmography was used to measure forearm blood flow responses to GTN. Compared to subjects with functional ALDH-2, the variant group exhibited blunted hemodynamic responses to intra-arterial GTN infusions, although this reduction in response was not statically significant. Contrary to our hypothesis, vitamin C had an inhibitory effect on GTN mediated vasodilation as compared to GTN during saline in both groups. We conclude that vitamin C did not augment the acute vascular response to GTN in those with the ALDH-2 polymorphism. |
Author | He, Jerry D. Parker, John D. |
Author_xml | – sequence: 1 givenname: Jerry D. surname: He fullname: He, Jerry D. organization: University of Toronto – sequence: 2 givenname: John D. orcidid: 0000-0003-1949-2669 surname: Parker fullname: Parker, John D. email: john.parker@uhn.ca organization: The Lunenfeld‐Tanenbaum Research Institute, Sinai Health System |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37101414$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kb1uFDEUhS0URDaBghdALkkxiX_GM7slrAggRSJFUlse-w5r5LEH27PRdNSp8ow8Cd6fNAgsS9fFd451zzlDJz54QOgtJZe0nKtOj5dUtEK8QAvKG1ExysQJWhBOmkowQU_RWUo_CKGcNuIVOuUtJbSm9QI93m0AQ9-Dzjj0eGuzGqzHaxw89jbH8N3NGqL1v389DWCsymDwVqVgrFPZFsrurrFbayblEn6weYOVN_tHmDLO5QPlDGxmA3g_iil4lQAzPAY3DyGOG5uG1-hlXxzgzXGeo_vrT3frL9XNt89f1x9uKs2ZEJURplGCMdFS3XFBdEtALVVd9mddLRQlumt0o0jPNKOrZc04b7slGN2B6Wrg5-j9wXeM4ecEKcvBJg3OKQ9hSpItSbNatQ2rC_ruiE5d2V6O0Q4qzvI5vwJcHQAdQ0oReqlLgrtcclTWSUrkriFZGpL7hori4i_Fs-m_2KP7g3Uw_x-UH9e3B8UfySijHw |
CitedBy_id | crossref_primary_10_3892_mmr_2025_13470 crossref_primary_10_1016_j_ijbiomac_2024_131091 crossref_primary_10_1080_14756366_2024_2367129 |
Cites_doi | 10.1016/j.jacc.2008.05.049 10.1161/01.CIR.0000030184.70207.FF 10.1016/S0163‐7827(03)00014‐6 10.1016/S0735‐1097(98)00085‐0 10.1023/A:1015867031004 10.1345/aph.19415 10.1016/j.jacc.2006.10.074 10.1111/bph.14751 10.1073/pnas.0503723102 10.1016/0891‐5849(91)90192‐6 10.1038/bjp.2008.263 10.1016/S0828‐282X(10)70448‐7 10.1016/S0140‐6736(02)46032‐1 10.1073/pnas.122225199 10.1590/S0100‐879X1999001100001 10.1046/j.0306‐5251.2001.01495.x 10.1016/S0022-3565(25)11096-3 10.1016/j.jacc.2017.09.1064 10.1089/ars.2015.6376 10.1038/sj.bjp.0707116 10.1016/S0031-6997(25)06667-0 10.1042/bj20041354 10.1093/eurheartj/9.suppl_A.33 10.1172/JCI977 10.1172/jci118449 10.1016/S0022-3565(24)35295-4 10.1111/bcp.13804 10.1152/ajpheart.00693.2002 10.1046/j.1523‐1755.2003.00852.x 10.1067/mcp.2002.125293 10.1016/j.niox.2013.09.003 10.1161/01.atv.0000179599.71086.89 10.1161/01.RES.0000184694.03262.6d 10.1016/j.cbi.2017.03.012 10.1124/mol.107.035642 10.1056/nejm199802193380807 10.1074/jbc.M801182200 10.1016/j.atherosclerosis.2007.06.011 10.1161/hc3501.095358 10.1161/hc4601.099485 10.1039/C4RA13315C 10.1172/JCI26564 10.1161/01.CIR.0000138105.17864.6B 10.1111/acer.12215 10.3389/fphys.2013.00105 10.1111/bph.14752 10.1136/bmjopen‐2011‐000133 10.1016/0002‐9149(92)90588‐P 10.1111/j.1365‐2125.2007.02864.x 10.1007/s10557‐016‐6668‐z 10.1111/j.1469‐1809.2009.00517.x 10.1097/00005344‐199905000‐00002 10.1152/jappl.2001.91.3.1421 10.1093/cvr/cvn107 10.1021/tx4004787 |
ContentType | Journal Article |
Copyright | 2023 British Pharmacological Society. |
Copyright_xml | – notice: 2023 British Pharmacological Society. |
DBID | AAYXX CITATION NPM 7X8 |
DOI | 10.1111/bcp.15755 |
DatabaseName | CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1365-2125 |
EndPage | 2774 |
ExternalDocumentID | 37101414 10_1111_bcp_15755 BCP15755 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: Canadian Institute for Health Research |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FIJ FUBAC G-S G.N GODZA GX1 H.X HF~ HGLYW HYE HZI HZ~ IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RPM RX1 SUPJJ TEORI TR2 UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGXDD AGYGG AIDQK AIDYY CITATION NPM 7X8 |
ID | FETCH-LOGICAL-c3255-d5d6a522571cb350c70ea8a45752b45a10cb6c6a0f2c219842337b8edcbedb4e3 |
IEDL.DBID | DR2 |
ISSN | 0306-5251 1365-2125 |
IngestDate | Fri Jul 11 11:58:54 EDT 2025 Thu Apr 03 07:06:16 EDT 2025 Thu Aug 14 00:01:06 EDT 2025 Thu Apr 24 23:05:29 EDT 2025 Wed Jan 22 16:17:23 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | aldehyde dehydrogenase 2 nitroglycerin bioactivation cardiovascular pharmacology vitamin C |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2023 British Pharmacological Society. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3255-d5d6a522571cb350c70ea8a45752b45a10cb6c6a0f2c219842337b8edcbedb4e3 |
Notes | The authors confirm that the Principal Investigator for this paper is Dr John D. Parker and that he had direct clinical responsibility for subjects. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-1949-2669 |
PMID | 37101414 |
PQID | 2806997624 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2806997624 pubmed_primary_37101414 crossref_citationtrail_10_1111_bcp_15755 crossref_primary_10_1111_bcp_15755 wiley_primary_10_1111_bcp_15755_BCP15755 |
PublicationCentury | 2000 |
PublicationDate | September 2023 2023-09-00 2023-Sep 20230901 |
PublicationDateYYYYMMDD | 2023-09-01 |
PublicationDate_xml | – month: 09 year: 2023 text: September 2023 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | British journal of clinical pharmacology |
PublicationTitleAlternate | Br J Clin Pharmacol |
PublicationYear | 2023 |
References | 2001; 91 2013; 4 1991; 11 2002; 99 2000; 292 2014; 27 2016; 30 2008; 79 2007; 72 2017; 276 2001; 104 2005; 25 1992; 9 2010; 26 2017; 70 2005; 385 1991; 43 2005; 102 2002; 106 2007; 64 2008; 155 2008; 197 2003; 42 2001; 52 2003; 284 2015; 5 1992; 261 2011; 1 1998; 338 2008; 52 2006; 116 2008; 283 1996; 97 1879; 113 2015; 23 2004; 110 1992; 70 2009; 73 2007; 150 1988; 9 2019; 85 2013; 35 2000; 34 2014; 38 2005; 97 1999; 33 1999; 32 2002; 71 1998; 102 2003; 63 1998; 31 2007; 49 2019; 176 e_1_2_10_23_1 e_1_2_10_46_1 e_1_2_10_21_1 e_1_2_10_44_1 e_1_2_10_42_1 e_1_2_10_40_1 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_53_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_39_1 e_1_2_10_55_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_11_1 e_1_2_10_32_1 e_1_2_10_30_1 e_1_2_10_51_1 e_1_2_10_29_1 e_1_2_10_27_1 e_1_2_10_25_1 e_1_2_10_48_1 e_1_2_10_24_1 e_1_2_10_45_1 e_1_2_10_22_1 e_1_2_10_43_1 e_1_2_10_20_1 e_1_2_10_41_1 e_1_2_10_52_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_54_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_38_1 e_1_2_10_56_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_36_1 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_9_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_31_1 e_1_2_10_50_1 e_1_2_10_28_1 e_1_2_10_49_1 e_1_2_10_26_1 e_1_2_10_47_1 |
References_xml | – volume: 30 start-page: 367 issue: 4 year: 2016 end-page: 378 article-title: Vasodilator therapy: nitrates and Nicorandil publication-title: Cardiovasc Drugs Ther – volume: 102 start-page: 12159 issue: 34 year: 2005 end-page: 12164 article-title: An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation publication-title: Proc Natl Acad Sci U S A – volume: 104 start-page: 1119 issue: 10 year: 2001 end-page: 1123 article-title: Folic acid prevents nitroglycerin‐induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study publication-title: Circulation – volume: 1 issue: 1 year: 2011 article-title: Differential effects of organic nitrates on arterial diameter among healthy Japanese participants with different mitochondrial aldehyde dehydrogenase 2 genotypes: randomised crossover trial publication-title: BMJ Open – volume: 176 start-page: S247 issue: Suppl 1 year: 2019 end-page: S296 article-title: The concise guide to pharmacology 2019/20: catalytic receptors publication-title: Br J Pharmacol – volume: 27 start-page: 663 issue: 4 year: 2014 end-page: 673 article-title: Role of the lipid peroxidation product, 4‐hydroxynonenal, in the development of nitrate tolerance publication-title: Chem Res Toxicol – volume: 72 start-page: 191 issue: 1 year: 2007 end-page: 196 article-title: Bioactivation of nitroglycerin by ascorbate publication-title: Mol Pharmacol – volume: 150 start-page: 526 issue: 4 year: 2007 end-page: 533 article-title: Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH‐2−/− mice publication-title: Br J Pharmacol – volume: 104 start-page: 2673 issue: 22 year: 2001 end-page: 2678 article-title: Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease publication-title: Circulation – volume: 52 start-page: 953 issue: 11 year: 2008 end-page: 960 article-title: Evidence for involvement of calcitonin gene‐related peptide in nitroglycerin response and association with mitochondrial aldehyde dehydrogenase‐2 (ALDH2) Glu504Lys polymorphism publication-title: J Am Coll Cardiol – volume: 91 start-page: 1421 issue: 3 year: 2001 end-page: 1430 article-title: Invited review: cGMP‐dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression publication-title: J Appl Physiol – volume: 26 start-page: 461 issue: 9 year: 2010 end-page: 465 article-title: Daily low‐dose folic acid supplementation does not prevent nitroglycerin‐induced nitric oxide synthase dysfunction and tolerance: a human in vivo study publication-title: Can J Cardiol – volume: 33 start-page: 685 issue: 5 year: 1999 end-page: 690 article-title: Biochemical, hemodynamic, and vascular evidence concerning the free radical hypothesis of nitrate tolerance publication-title: J Cardiovasc Pharmacol – volume: 42 start-page: 318 issue: 4 year: 2003 end-page: 343 article-title: 4‐Hydroxy‐2‐nonenal: a product and mediator of oxidative stress publication-title: Prog Lipid Res – volume: 79 start-page: 304 issue: 2 year: 2008 end-page: 312 article-title: Vascular tolerance to nitroglycerin in ascorbate deficiency publication-title: Cardiovasc Res – volume: 338 start-page: 520 issue: 8 year: 1998 end-page: 531 article-title: Nitrate therapy for stable angina pectoris publication-title: N Engl J Med – volume: 283 start-page: 17873 issue: 26 year: 2008 end-page: 17880 article-title: Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases publication-title: J Biol Chem – volume: 197 start-page: 383 issue: 1 year: 2008 end-page: 391 article-title: Intra‐arterial vitamin C prevents endothelial dysfunction caused by ischemia‐reperfusion publication-title: Atherosclerosis – volume: 97 start-page: 618 issue: 7 year: 2005 end-page: 628 article-title: Explaining the phenomenon of nitrate tolerance publication-title: Circ Res – volume: 49 start-page: 1289 issue: 12 year: 2007 end-page: 1295 article-title: Once daily therapy with isosorbide‐5‐mononitrate causes endothelial dysfunction in humans: evidence of a free‐radical‐mediated mechanism publication-title: J Am Coll Cardiol – volume: 43 start-page: 351 issue: 3 year: 1991 end-page: 423 article-title: Organic nitrate esters: clinical use and mechanisms of actions publication-title: Pharmacol Rev – volume: 23 start-page: 899 issue: 11 year: 2015 end-page: 942 article-title: Organic nitrate therapy, nitrate tolerance, and nitrate‐induced endothelial dysfunction: emphasis on redox biology and oxidative stress publication-title: Antioxid Redox Signal – volume: 102 start-page: 67 issue: 1 year: 1998 end-page: 71 article-title: Dietary supplement with vitamin C prevents nitrate tolerance publication-title: J Clin Invest – volume: 31 start-page: 1323 issue: 6 year: 1998 end-page: 1329 article-title: Randomized, double‐blind, placebo‐controlled study of the preventive effect of supplemental oral vitamin C on attenuation of development of nitrate tolerance publication-title: J Am Coll Cardiol – volume: 9 start-page: 1460 issue: 11 year: 1992 end-page: 1464 article-title: Glutathione S‐transferase‐mediated metabolism of glyceryl trinitrate in subcellular fractions of bovine coronary arteries publication-title: Pharm Res – volume: 155 start-page: 170 issue: 2 year: 2008 end-page: 184 article-title: The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles publication-title: Br J Pharmacol – volume: 110 start-page: 750 issue: 6 year: 2004 end-page: 755 article-title: Role of mitochondrial aldehyde dehydrogenase in nitroglycerin‐induced vasodilation of coronary and systemic vessels: an intact canine model publication-title: Circulation – volume: 276 start-page: 40 year: 2017 end-page: 45 article-title: Vasodilatory effect of nitroglycerin in Japanese subjects with different aldehyde dehydrogenase 2 (ALDH2) genotypes publication-title: Chem Biol Interact – volume: 116 start-page: 506 issue: 2 year: 2006 end-page: 511 article-title: Mitochondrial aldehyde dehydrogenase‐2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin publication-title: J Clin Invest – volume: 106 start-page: 1460 issue: 12 year: 2002 end-page: 1464 article-title: High doses of vitamin C reverse endotoxin‐induced hyporeactivity to acetylcholine in the human forearm publication-title: Circulation – volume: 71 start-page: 440 issue: 6 year: 2002 end-page: 447 article-title: Angiotensin II attenuates the vasodilating effect of a nitric oxide donor, glyceryl trinitrate: roles of superoxide and angiotensin II type 1 receptors publication-title: Clin Pharmacol Ther – volume: 25 start-page: 1891 issue: 9 year: 2005 end-page: 1895 article-title: Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans publication-title: Arterioscler Thromb Vasc Biol – volume: 97 start-page: 562 issue: 2 year: 1996 end-page: 576 article-title: Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs publication-title: J Clin Invest – volume: 99 start-page: 8306 issue: 12 year: 2002 end-page: 8311 article-title: Identification of the enzymatic mechanism of nitroglycerin bioactivation publication-title: Proc Natl Acad Sci U S A – volume: 38 start-page: 44 issue: 1 year: 2014 end-page: 50 article-title: Dominance of the inactive Asian variant over activity and protein contents of mitochondrial aldehyde dehydrogenase 2 in human liver publication-title: Alcohol Clin Exp Res – volume: 85 start-page: 377 issue: 2 year: 2019 end-page: 384 article-title: The role of vascular endothelium in nitroglycerin‐mediated vasodilation publication-title: Br J Clin Pharmacol – volume: 73 start-page: 335 issue: 3 year: 2009 end-page: 345 article-title: Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant publication-title: Ann Hum Genet – volume: 113 start-page: 80 issue: 2890 year: 1879 end-page: 81 article-title: Nitro‐GLYCERINE as a remedy for angina pectoris publication-title: Lancet – volume: 52 start-page: 631 issue: 6 year: 2001 end-page: 646 article-title: Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications publication-title: Br J Clin Pharmacol – volume: 32 start-page: 1317 issue: 11 year: 1999 end-page: 1327 article-title: Cellular signaling with nitric oxide and cyclic GMP publication-title: Braz J Med Biol Res = Rev Bras Pesquis Med Biol – volume: 292 start-page: 326 issue: 1 year: 2000 end-page: 330 article-title: Inhibition of platelet aggregation with glyceryl trinitrate and xanthine oxidoreductase publication-title: J Pharmacol Exp Ther – volume: 64 start-page: 145 issue: 2 year: 2007 end-page: 150 article-title: Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight publication-title: Br J Clin Pharmacol – volume: 34 start-page: 1193 issue: 10 year: 2000 end-page: 1197 article-title: Vitamin C in the prevention of nitrate tolerance publication-title: Ann Pharmacother – volume: 284 start-page: H698 issue: 2 year: 2003 end-page: H703 article-title: Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid publication-title: Am J Physiol Heart Circ Physiol – volume: 176 start-page: S297 issue: Suppl 1 year: 2019 end-page: S396 article-title: The concise guide to pharmacology 2019/20: enzymes publication-title: Br J Pharmacol – volume: 70 start-page: B4 issue: 8 year: 1992 end-page: B10 article-title: Biochemical mechanism of organic nitrate action publication-title: Am J Cardiol – volume: 11 start-page: 81 issue: 1 year: 1991 end-page: 128 article-title: Chemistry and biochemistry of 4‐hydroxynonenal, malonaldehyde and related aldehydes publication-title: Free Radic Biol Med – volume: 35 start-page: 116 year: 2013 end-page: 122 article-title: Catalysis of nitrite generation from nitroglycerin by glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH) publication-title: Nitric Oxide – volume: 261 start-page: 716 issue: 2 year: 1992 end-page: 723 article-title: Hepatic cytochrome P‐450‐mediated activation of rat aortic guanylyl cyclase by glyceryl trinitrate publication-title: J Pharmacol Exp Ther – volume: 5 start-page: 27986 issue: 35 year: 2015 end-page: 28006 article-title: Free radicals, natural antioxidants, and their reaction mechanisms publication-title: RSC Adv – volume: 63 start-page: 1433 issue: 4 year: 2003 end-page: 1442 article-title: Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure publication-title: Kidney Int – volume: 9 start-page: 33 issue: suppl A year: 1988 end-page: 37 article-title: Pharmacokinetics of organic nitrates in man: an overview publication-title: Eur Heart J – volume: 385 start-page: 769 issue: 3 year: 2005 end-page: 777 article-title: Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxide publication-title: Biochem J – volume: 70 start-page: 2393 issue: 19 year: 2017 end-page: 2410 article-title: The role of nitroglycerin and other nitrogen oxides in cardiovascular therapeutics publication-title: J am Coll Cardiol – volume: 4 year: 2013 article-title: Angiotensin‐II‐derived reactive oxygen species on baroreflex sensitivity during hypertension: new perspectives publication-title: Front Physiol – ident: e_1_2_10_25_1 doi: 10.1016/j.jacc.2008.05.049 – ident: e_1_2_10_37_1 doi: 10.1161/01.CIR.0000030184.70207.FF – ident: e_1_2_10_29_1 doi: 10.1016/S0163‐7827(03)00014‐6 – ident: e_1_2_10_55_1 doi: 10.1016/S0735‐1097(98)00085‐0 – ident: e_1_2_10_12_1 doi: 10.1023/A:1015867031004 – ident: e_1_2_10_32_1 doi: 10.1345/aph.19415 – ident: e_1_2_10_34_1 doi: 10.1016/j.jacc.2006.10.074 – ident: e_1_2_10_42_1 doi: 10.1111/bph.14751 – ident: e_1_2_10_45_1 doi: 10.1073/pnas.0503723102 – ident: e_1_2_10_28_1 doi: 10.1016/0891‐5849(91)90192‐6 – ident: e_1_2_10_43_1 doi: 10.1038/bjp.2008.263 – ident: e_1_2_10_39_1 doi: 10.1016/S0828‐282X(10)70448‐7 – ident: e_1_2_10_3_1 doi: 10.1016/S0140‐6736(02)46032‐1 – ident: e_1_2_10_15_1 doi: 10.1073/pnas.122225199 – ident: e_1_2_10_9_1 doi: 10.1590/S0100‐879X1999001100001 – ident: e_1_2_10_33_1 doi: 10.1046/j.0306‐5251.2001.01495.x – ident: e_1_2_10_11_1 doi: 10.1016/S0022-3565(25)11096-3 – ident: e_1_2_10_4_1 doi: 10.1016/j.jacc.2017.09.1064 – ident: e_1_2_10_44_1 doi: 10.1089/ars.2015.6376 – ident: e_1_2_10_20_1 doi: 10.1038/sj.bjp.0707116 – ident: e_1_2_10_8_1 doi: 10.1016/S0031-6997(25)06667-0 – ident: e_1_2_10_19_1 doi: 10.1042/bj20041354 – ident: e_1_2_10_5_1 doi: 10.1093/eurheartj/9.suppl_A.33 – ident: e_1_2_10_31_1 doi: 10.1172/JCI977 – ident: e_1_2_10_51_1 doi: 10.1172/jci118449 – ident: e_1_2_10_14_1 doi: 10.1016/S0022-3565(24)35295-4 – ident: e_1_2_10_38_1 doi: 10.1111/bcp.13804 – ident: e_1_2_10_50_1 doi: 10.1152/ajpheart.00693.2002 – ident: e_1_2_10_47_1 doi: 10.1046/j.1523‐1755.2003.00852.x – ident: e_1_2_10_53_1 doi: 10.1067/mcp.2002.125293 – ident: e_1_2_10_13_1 doi: 10.1016/j.niox.2013.09.003 – ident: e_1_2_10_24_1 doi: 10.1161/01.atv.0000179599.71086.89 – ident: e_1_2_10_54_1 doi: 10.1161/01.RES.0000184694.03262.6d – ident: e_1_2_10_22_1 doi: 10.1016/j.cbi.2017.03.012 – ident: e_1_2_10_17_1 doi: 10.1124/mol.107.035642 – ident: e_1_2_10_2_1 doi: 10.1056/nejm199802193380807 – ident: e_1_2_10_16_1 doi: 10.1074/jbc.M801182200 – ident: e_1_2_10_35_1 doi: 10.1016/j.atherosclerosis.2007.06.011 – ident: e_1_2_10_40_1 doi: 10.1161/hc3501.095358 – ident: e_1_2_10_36_1 doi: 10.1161/hc4601.099485 – ident: e_1_2_10_48_1 doi: 10.1039/C4RA13315C – ident: e_1_2_10_26_1 doi: 10.1172/JCI26564 – ident: e_1_2_10_18_1 doi: 10.1161/01.CIR.0000138105.17864.6B – ident: e_1_2_10_46_1 doi: 10.1111/acer.12215 – ident: e_1_2_10_52_1 doi: 10.3389/fphys.2013.00105 – ident: e_1_2_10_41_1 doi: 10.1111/bph.14752 – ident: e_1_2_10_23_1 doi: 10.1136/bmjopen‐2011‐000133 – ident: e_1_2_10_7_1 doi: 10.1016/0002‐9149(92)90588‐P – ident: e_1_2_10_49_1 doi: 10.1111/j.1365‐2125.2007.02864.x – ident: e_1_2_10_6_1 doi: 10.1007/s10557‐016‐6668‐z – ident: e_1_2_10_21_1 doi: 10.1111/j.1469‐1809.2009.00517.x – ident: e_1_2_10_56_1 doi: 10.1097/00005344‐199905000‐00002 – ident: e_1_2_10_10_1 doi: 10.1152/jappl.2001.91.3.1421 – ident: e_1_2_10_30_1 doi: 10.1093/cvr/cvn107 – ident: e_1_2_10_27_1 doi: 10.1021/tx4004787 |
SSID | ssj0013165 |
Score | 2.4297333 |
Snippet | Aims
To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The... To mediate its pharmacodynamic effects, glyceryl trinitrate (GTN) requires bioactivation, by which it releases nitric oxide or a nitric oxide moiety. The exact... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2767 |
SubjectTerms | aldehyde dehydrogenase 2 cardiovascular pharmacology nitroglycerin bioactivation vitamin C |
Title | The effect of vitamin C on nitroglycerin‐mediated vasodilation in individuals with and without the aldehyde dehydrogenase 2 polymorphism |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbcp.15755 https://www.ncbi.nlm.nih.gov/pubmed/37101414 https://www.proquest.com/docview/2806997624 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Ja9wwFBYhp166pNu0TXktJeQQD17kZcipHRpCoWUoCeRQMFretKYz1hB7As4p557yG_tL-iSNZ5ouUAoGGyQLS37L96S3MPYqzzHVoRIBRnkWcDnFYKQ5Bih5zHMUpPPt1sD7D9nxKX93lp5tscM-Fsbnh1hvuFnOcPLaMriQzU9MLtViGBHYsAHm1lfLAqKP8eYEIXJlJC0kJmMrjVZZhawXz_rNm7roN4B5E686hXN0h33qP9X7mXwdLls5VJe_ZHH8z7ncZbdXQBRee8q5x7aw3mF7E5_JujuAk01gVnMAezDZ5Lju7rNv1AzeFwTMFC6qVsyrGsZgaiAhcW4-zzplIwu_X1274BQCtnAhGqMr73wHlb36YLAG7H4wiFq7B7NsgYApiJnGL51GcDcaFGtSuhDDwsy6uSESqZr5A3Z69PZkfBysyjoEKiEDJtCpzgTBvjSPlEzSUOUhikJwmn8seSqiUMlMZSKcxorkaUGAL8llgVpJ1JJj8pBt16bGxwxSQnfFlOvRCJHsKCELh9-4IhkfylAP2H7_g0u1ynluS2_Myt72oZUv3coP2Mt114VP9PGnTi96KimJDe3ZiqjRLJvSHlCPCNrFfMAeefJZD5PktiByRC37jgj-Pn75ZjxxD0_-vetTdism4OX93p6x7fZ8ibsElFr53HHED3dYEjc |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9RAEG7W9aAX34_xWYose9gMeXQnGfCig8uou8sgs7AXCf2o0eBMMmwyC_Hk2ZO_0V9idWcy4_oAEQIJdKdJd6qqv6quB2PPkgSF8bX0MEhij6spegPD0UPFQ56gpD3fmgYOj-LRMX9zIk622PMuFqbND7E2uFnOcPLaMrg1SP_E5Uov-gGhDXGBXbQVvZ1C9S7cnCEErpCkBcWkbolglVfI-vGsXz2_G_0GMc8jVrfl7F9l77uPbT1NPvWXterrz7_kcfzf2VxjV1ZYFF60xHOdbWFxg-2M22TWzR5MNrFZ1R7swHiT5rq5yb5SM7TuIFBO4Syv5TwvYAhlASQnTssPs0bb4MLvX765-BTCtnAmq9Lkrf8d5Pbq4sEqsCZhkIVxD-WyBsKmIGcGPzYGwd1oUCxo34UQFuWsmZdEJXk1v8WO919NhiNvVdnB0xHpMJ4RJpaE_EQSaBUJXyc-ylRymn-ouJCBr1WsY-lPQ00iNSXMFyUqRaMVGsUxus22i7LAuwwEAbx0ys1ggEiqlFSpg3Bck5j3lW96bLf7w5lepT231TdmWaf-0MpnbuV77Om666LN9fGnTk86MsmIE-3xiiywXFaZPaMeELoLeY_daelnPUyU2JrIAbXsOir4-_jZy-HYPdz7966P2aXR5PAgO3h99PY-uxwSDmvd4B6w7fp0iQ8JN9XqkWOPH3toFlI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Ja9tAFB7SFEovabrGXV9LCTlERstoMT21Tk26BVMSyKEgZnlqRGzJRHJAPfWcU39jf0nfjCy76QKlIJBgRoNm9JbvzbyFsedxjKF2lXDQiyOHywydgebooOQ-j1GQzjdbAx8Oov0j_vY4PF5jL7pYmDY_xHLDzXCGldeGwWc6-4nJpZr1PQIb4RV2lUduYkh676O_OkLwbB1Jg4nJ2gq9RVoh48azfPWyMvoNYV4GrFbjjG6wT923to4mp_15Lfvqyy9pHP9zMptsY4FE4WVLOjfZGha32Pa4TWXd7MLhKjKr2oVtGK-SXDe32QU1Q-sMAmUG53ktpnkBQygLIClxVn6eNMqEFn7_-s1GpxCyhXNRlTpvve8gN1cXDVaB2RAGUWj7UM5rIGQKYqLxpNEI9kaDYkFaF3yYlZNmWhKN5NX0DjsavT4c7juLug6OCsiCcXSoI0G4L4w9JYPQVbGLIhGc5u9LHgrPVTJSkXAzX5FATQjxBbFMUCuJWnIM7rL1oixwi0FI8C7JuB4MEMmQEjKxAI4rEvKudHWP7XQ_OFWLpOem9sYk7YwfWvnUrnyPPVt2nbWZPv7U6WlHJSnxoTlcEQWW8yo1J9QDwnY-77F7LfkshwliUxHZo5YdSwR_Hz99NRzbh_v_3vUJuzbeG6Xv3xy8e8Cu-wTCWh-4h2y9PpvjIwJNtXxsmeMHURIVCg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+vitamin+C+on+nitroglycerin-mediated+vasodilation+in+individuals+with+and+without+the+aldehyde+dehydrogenase+2+polymorphism&rft.jtitle=British+journal+of+clinical+pharmacology&rft.au=He%2C+Jerry+D&rft.au=Parker%2C+John+D&rft.date=2023-09-01&rft.issn=1365-2125&rft.eissn=1365-2125&rft.volume=89&rft.issue=9&rft.spage=2767&rft_id=info:doi/10.1111%2Fbcp.15755&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0306-5251&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0306-5251&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0306-5251&client=summon |